PFW
HUMA icon

Petros Family Wealth’s Humacyte HUMA Stock Holding History

Petros Family Wealth’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,000
Closed -$50.5K – 131
2024
Q4 		$50.5K Buy
+10,000
New +$49.5K 0.05% 129

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Petros Family Wealth's HUMA Position: Q1 2025 in Review

Petros Family Wealth sold out of Humacyte (HUMA) in Q1 2025, closing a stake of 10,000 shares — an estimated $50.5K sold.

Petros Family Wealth first reported a position in HUMA in Q4 2024 and held it in 1 quarter. The position peaked at $50.5K in Q4 2024. 168 funds tracked by Wall St. Rank hold HUMA as of Q1 2025.

  • Petros Family Wealth reported no remaining Humacyte position as of Q1 2025 after selling out during the quarter.
  • Petros Family Wealth sold 10,000 Humacyte shares in Q1 2025, an estimated $50.5K.
  • Petros Family Wealth first reported a position in Humacyte in Q4 2024 and held it in 1 quarter.
  • Petros Family Wealth's Humacyte position peaked at $50.5K in Q4 2024.
  • 168 funds tracked by Wall St. Rank held Humacyte as of Q1 2025.

Based on Petros Family Wealth's 13F filing for Q1 2025, filed 23 Apr 2025.